Stromal-Derived Factor-1 and Inflammatory Cytokines in Retinal Vein Occlusion

REFERENCES

• Hayreh S S, Zimmerman M B, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117: 429–441
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis. Adv Cancer Res 1974; 19: 331–358
   PubMedGoogle Scholar
• Wiedemann P. Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 1992; 36: 373–384
   PubMed Web of Science ®Google Scholar
• Ratajczak M Z, Zuba-Surma E, Kucia M, et al. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006; 20: 1915–1924
   PubMed Web of Science ®Google Scholar
• Ruiz d e, Almodovar C, Luttun A, Carmeliet P. An SDF-1 trap for myeloid cells stimulates angiogenesis. Cell 2006; 124: 18–21
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Kusano K F, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107: 1322–1328
   PubMed Web of Science ®Google Scholar
• Salvucci O, Yao L, Villalba S, et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002; 99: 2703–2711
   PubMed Web of Science ®Google Scholar
• Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 2006; 124: 175–189
   PubMed Web of Science ®Google Scholar
• Ceradini D J, Kulkarni A R, Callaghan M J, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858–864
   PubMed Web of Science ®Google Scholar
• Brooks H L, Jr, Caballero S, Jr, Newell C K, et al. Vitreous levels of vascular endothelial growth factor and stromal-derived factor1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 2004; 122: 1801–1807
   PubMed Web of Science ®Google Scholar
• Butler J M, Guthrie S M, Koc M, et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 2005; 115: 86–93
   PubMed Web of Science ®Google Scholar
• Aiello L P, Avery R L, Arrigg P G, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480–1487
   PubMed Web of Science ®Google Scholar
• Motro B, Itin A, Sachs L, Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 1990; 87: 3092–3096
   PubMed Web of Science ®Google Scholar
• Koch A E, Polverini P J, Kunkel S L, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798–1801
   PubMed Web of Science ®Google Scholar
• Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635–638
   PubMed Web of Science ®Google Scholar
• Stumm R K, Rummel J, Junker V, et al. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: Isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 2002; 22: 5865–5878
   PubMed Web of Science ®Google Scholar
• Gombert M, Dieu-Nosjean M C, Winterberg F, et al. CCL1-CCR8 interactions: An axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 2005; 174: 5082–5091
   PubMed Web of Science ®Google Scholar
• Khan S S, Smith M S, Reda D, et al. Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry 2004; 61: 35–39
   PubMedGoogle Scholar
• Tanaka Y, Katoh S, Hori S, et al. Vascular endothelial growth factor in diabetic retinopathy. Lancet 1997; 349: 1520
   PubMed Web of Science ®Google Scholar
• Klok A M, Luyendijk L, Zaal M J, et al. Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis. Br J Ophthalmol 1998; 82: 871–874
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Noma H, et al. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 2002; 133: 70–77
   PubMed Web of Science ®Google Scholar
• Adamis A P. Is diabetic retinopathy an inflammatory disease?. Br J Ophthalmol 2002; 86: 363–365
   PubMed Web of Science ®Google Scholar
• Odemis V, Moepps B, Gierschik P, Engele J. Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression. Implications for brain inflammation. J Biol Chem 2002; 277: 39801–39808
   PubMed Web of Science ®Google Scholar
• Meleth A D, Agron E, Chan C C, et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46: 4295–4301
   PubMed Web of Science ®Google Scholar
• Caldwell R B, Bartoli M, Behzadian M A, et al. Vascular endothelial growth factor and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Diabetes/metabolism Research and Reviews 2003; 19: 442–455
   PubMed Web of Science ®Google Scholar
• Spranger J, Buhnen J, Jansen V, et al. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Horm Metab Res 2000; 32: 196–200
   PubMed Web of Science ®Google Scholar